Largest profit: Delidrengene ApS (2016) '600 DKK
Most equity: Delidrengene ApS (2017) '1,558 DKK
Biggest loss: Delidrengene ApS (2013) '138 DKK
Active
Director (2008-03-14 - present)
Board member (2018-03-01 - present)
Ultimate beneficial owner (2006-12-21 - 2025-02-05) 45% ownership (2006-12-21 – 2025-02-05 ) 45% voting rights (2006-12-21 – 2025-02-05 )
Board member (2008-03-14 - 2012-06-04)